| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/GLIA.10067 |
| P698 | PubMed publication ID | 11948809 |
| P50 | author | Divya M Chari | Q63696595 |
| P2093 | author name string | W F Blakemore | |
| A J Crang | |||
| J M Gilson | |||
| P2860 | cites work | Schwann cells transplanted into normal and X-irradiated adult white matter do not migrate extensively and show poor long-term survival. | Q50510445 |
| Suppression of remyelination in the CNS by X-irradiation | Q67337430 | ||
| Extensive Oligodendrocyte Remyelination following Injection of Cultured Central Nervous System Cells into Demyelinating Lesions in Adult Central Nervous System | Q68363978 | ||
| The effect of the number of oligodendrocytes transplanted into X-irradiated, glial-free lesions on the extent of oligodendrocyte remyelination | Q69793575 | ||
| Delayed infarction of spinal cord white matter following x-irradiation | Q70405673 | ||
| Transplanted glial cells migrate over a greater distance and remyelinate demyelinated lesions more rapidly than endogenous remyelinating cells | Q74016311 | ||
| Areas of demyelination do not attract significant numbers of schwann cells transplanted into normal white matter | Q74166426 | ||
| Efficient recolonisation of progenitor-depleted areas of the CNS by adult oligodendrocyte progenitor cells | Q77707852 | ||
| Transplantation of clonal neural precursor cells derived from adult human brain establishes functional peripheral myelin in the rat spinal cord | Q28143116 | ||
| Co-localization of NG2 proteoglycan and PDGF alpha-receptor on O2A progenitor cells in the developing rat brain | Q28565002 | ||
| A common neural progenitor for the CNS and PNS. | Q34067171 | ||
| Remyelination and restoration of axonal function by glial cell transplantation | Q34120819 | ||
| Transplantation of glial cells enhances action potential conduction of amyelinated spinal cord axons in the myelin-deficient rat | Q34885824 | ||
| Distinctive patterns of PDGF-A, FGF-2, IGF-I, and TGF-beta1 gene expression during remyelination of experimentally-induced spinal cord demyelination. | Q40792686 | ||
| Embryonic stem cell-derived glial precursors: a source of myelinating transplants | Q40938819 | ||
| Local recruitment of remyelinating cells in the repair of demyelination in the central nervous system | Q41066214 | ||
| Reconstruction of the glial environment of a photochemically induced lesion in the rat spinal cord by transplantation of mixed glial cells | Q41177376 | ||
| Transplanted CG4 cells (an oligodendrocyte progenitor cell line) survive, migrate, and contribute to repair of areas of demyelination in X-irradiated and damaged spinal cord but not in normal spinal cord | Q41233816 | ||
| Type 1 astrocytes fail to inhibit Schwann cell remyelination of CNS axons in the absence of cells of the O-2A lineage. | Q41648460 | ||
| Transplantation of Normal and Genetically Engineered Glia into Areas of Demyelination | Q41705480 | ||
| Cooperation between PDGF and FGF converts slowly dividing O-2Aadult progenitor cells to rapidly dividing cells with characteristics of O-2Aperinatal progenitor cells | Q43108447 | ||
| Depletion of endogenous oligodendrocyte progenitors rather than increased availability of survival factors is a likely explanation for enhanced survival of transplanted oligodendrocyte progenitors in X-irradiated compared to normal CNS. | Q48921303 | ||
| P433 | issue | 2 | |
| P921 | main subject | neuroglia | Q177105 |
| P304 | page(s) | 155-168 | |
| P577 | publication date | 2002-04-01 | |
| P1433 | published in | Glia | Q15716658 |
| P1476 | title | Modelling large areas of demyelination in the rat reveals the potential and possible limitations of transplanted glial cells for remyelination in the CNS | |
| P478 | volume | 38 |
| Q26860077 | Applications of SPR for the characterization of molecules important in the pathogenesis and treatment of neurodegenerative diseases |
| Q38957246 | Biochemical, cell biological, pathological, and therapeutic aspects of Krabbe's disease |
| Q35648117 | Cell therapy for multiple sclerosis |
| Q36415316 | Clinical canine spinal cord injury provides an opportunity to examine the issues in translating laboratory techniques into practical therapy. |
| Q50994586 | Cortical Remyelination Is Heterogeneous in Multiple Sclerosis. |
| Q30500898 | Glial grafting for demyelinating disease. |
| Q100535719 | Glial restricted precursor cells in central nervous system disorders: Current applications and future perspectives |
| Q37351589 | Immunological demyelination triggers macrophage/microglial cells activation without inducing astrogliosis |
| Q44451929 | Impaired remyelination and depletion of oligodendrocyte progenitors does not occur following repeated episodes of focal demyelination in the rat central nervous system |
| Q33740931 | Importance of oligodendrocyte protection, BBB breakdown and inflammation for remyelination. |
| Q57042167 | Multiple paths towards repair in multiple sclerosis |
| Q33772195 | Myelin recovery in multiple sclerosis: the challenge of remyelination |
| Q34172960 | Neuro-immune interactions of neural stem cell transplants: from animal disease models to human trials |
| Q41812779 | Oligodendrocytes engineered with migratory proteins as effective graft source for cell transplantation in multiple sclerosis |
| Q21129352 | Oligodendrogenesis in the normal and pathological central nervous system |
| Q86854226 | Oligoprogenitor cells derived from spermatogonia stem cells improve remyelination in demyelination model |
| Q38538932 | Pharmacological approaches to intervention in hypomyelinating and demyelinating white matter pathology |
| Q27004382 | Precursor cell biology and the development of astrocyte transplantation therapies: lessons from spinal cord injury |
| Q27010398 | Promoting remyelination in multiple sclerosis-recent advances |
| Q38261543 | Remyelinating strategies in multiple sclerosis |
| Q78861248 | Remyelination in multiple sclerosis |
| Q34632031 | Remyelination in multiple sclerosis. |
| Q38655682 | Rodent, large animal and non-human primate models of spinal cord injury |
| Q37676004 | Strategies for protecting oligodendrocytes and enhancing remyelination in multiple sclerosis |
| Q36713824 | The biosynthesis and catabolism of galactosaminoglycans |
| Q36000878 | The case for a central nervous system (CNS) origin for the Schwann cells that remyelinate CNS axons following concurrent loss of oligodendrocytes and astrocytes |
| Q44760157 | The presence of astrocytes in areas of demyelination influences remyelination following transplantation of oligodendrocyte progenitors |
| Q45049883 | The remyelinating potential and in vitro differentiation of MOG-expressing oligodendrocyte precursors isolated from the adult rat CNS. |
| Q38111421 | The road to remyelination in demyelinating diseases: current status and prospects for clinical treatment. |
Search more.